DONATE TO ADVANCE RESEARCH AND SAVE THE LIVES OF WOMEN LIKE ALISHA

ONE WOMAN DIES EVERY 4 HOURS FROM A GYNAECOLOGICAL CANCER

Donations like yours, no matter how big or small, ensure we can continue to advance research and save lives.

6,800 Australian and 1,000 New Zealand women (wahine) are diagnosed with one of the seven gynaecological cancers every year.

Your life changing generosity to WomenCan contributes to the cancer research programs of Australia New Zealand Gynaecological Oncology Group (ANZGOG), improving outcomes for everyone with a lived experience of gynaecological cancer.

GYNAECOLOGICAL CANCER IN AUSTRALIA

alarm

1 woman dies every 4 hours

show_chart

6,777 women diagnosed every year

assignment_late

1 IN 23 WOMEN RISK DIAGNOSIS

“i DIDN'T THINK I WOULD SURVIVE SIX MONTHS”

“It was a friday afternoon when I received a call from my GP. I was about to head off on a girls weekend away, instead they called my mum and I in to deliver the devastating news,” says Alisha. “The future I had been planning was instantly ripped away from me.”

Alisha had a successful career in medicine and flourishing social life. She was just 27 years old when she was diagnosed with stage 4 ovarian cancer.

Alisha began chemotherapy and was given the news that it was unlikely treatment would work. "The prognosis at that stage was quite poor and in my head I felt that I wasn't going to be around for long," says Alisha.

Alisha's cancer was extensive, with spots in her lymph nodes, abdomen and breasts. But initial chemotherapy showed signs of success, so doctors proceeded with surgery, further chemotherapy, and radiation.

Today, 7 years on, Alisha is here to tell her story. It’s something that she attributes to her incredible oncologist, who is also an ANZGOG member. "She has always been up to date with the latest research and treatments, making sure I had access to the best available options for my cancer. We trialled new methods which worked." says Alisha

Currently, only 49% of women with ovarian cancer survive five years after diagnosis, meaning more than half will lose their life to the disease. It is vital that further research is supported to find new breakthroughs. Alisha is not cancer free and holds out hope for new breakthrough research and trials that will continue to extend her life.

Please make a tax-deductible donation today to support ANZGOG’s pioneering research to give hope to women like Alisha. "Research is hope and without research I don't have any hope," says Alisha.

anzgog's research impact

assessment

24 years

ANZGOG has been improving life for women through research since 2000.

assignment_ind

over 40 trials

ANZGOG has enabled more than 40 clinical trials and studies across a range of gynaecological cancers.

group

4,000+ women

More than 4,000 patients have participated in ANZGOG's clinical trials.

funding research is critical

Research is the only way to make the next new breakthrough for women affected by gynaecological cancers.

Clinical trials are the only way we can demonstrate the effectiveness of new treatments which can then become available to all patients. In addition, for many women participating in the trials, it means they will gain access to the newest treatments available for their condition.

Assoc Prof Philip Beale,
Medical Oncologist & ANZGOG Director

 

WomenCan fundraises for the Australia New Zealand Gynaecological Oncology Group (ANZGOG), the peak national clinical trials research organisation for gynaecological cancer in Australia and New Zealand.

Our mission is to engage the community to fund research which is driven by evidence of need and an ambition to change practice, improve outcomes and provide hope.

#researchsaveslives